Evidence map›Paper›PMID 32005661›Full record

ArticleThe Journal of biological chemistry2020

Exploring

Conor J Crawford, Radamés J B Cordero, Lorenzo Guazzelli, Maggie P Wear, Anthony Bowen, Stefan Oscarson, Arturo Casadevall

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Set202 is a histone lysine methyltransferase that enablesbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. mBio · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A glycan FRET assay for detection and characterization of catalytic antibodies to theProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. A synthetic glycan array containingChemical science · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Conor J CrawfordCentre for Synthesis and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland; Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205.
Radamés J B CorderoDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205.
Lorenzo GuazzelliCentre for Synthesis and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland.
Maggie P WearDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205.
Anthony BowenDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205.
Stefan OscarsonCentre for Synthesis and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: stefan.oscarson@ucd.ie.
Arturo CasadevallDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205. Electronic address: acasade1@jhu.edu.
Johns Hopkins University · USUniversity College Dublin · IE

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Training: Molecular & Cellular Bases of Infectious DiseasesT32AI007417 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall · 1994 to 2026
$11.9M
Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
NHLBI NIH HHS R01 HL059842NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI052733NIAID NIH HHS T32 AI007417
6 · The paper itself

Abstract

Chemical biology is an emerging field that enables the study and manipulation of biological systems with probes whose reactivities provide structural insights. The opportunistic fungal pathogen

Indexed as

CapsulesCell WallCryptococcosisCryptococcus neoformansFluorescent DyesFungal ProteinsHumansHydroxylaminesPolysaccharidesVirulenceVirulence FactorsCapsulesFluorescent DyesFungal ProteinsHydroxylaminesPolysaccharidesVirulence Factorsaminooxy fluorescent probesbiosynthesiscapsulechemical biologyextracellular vesiclesfungal pathogenfungiglucuronoxylomannanglycobiologypolysaccharidereducing glycansvesiclesvirulence factor

Identifiers

PMID32005661
PMCPMC7105310
OpenAlexW3004071649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.